Ryan T P, Steenwyk R C, Pearson P G, Petry T W
Investigative Toxicology, Upjohn Laboratories, Kalamazoo, MI 49001.
Biochem Pharmacol. 1993 Sep 1;46(5):877-84. doi: 10.1016/0006-2952(93)90497-k.
In a previous report (Ryan and Petry, Arch Biochem Biophys 300: 699-704, 1993), the effects of two 21-aminosteroids (U-74500A and U-74006F) on the oxidation and reduction of iron in a buffer/organic solvent system were investigated. In those studies, U-74500A was found to be an efficient iron reductant and potential iron chelator, whereas U-74006F had little effect on iron redox chemistry. As an extension of those studies, we now report the effects of U-74006F and U-74500A on lipid peroxidation in systems that are dependent upon iron oxidation/reduction. In liposomes, U-74500A inhibited ADP:Fe(II)-dependent lipid peroxidation in a concentration-dependent manner, whereas U-74006F was minimally effective in this system. The mechanism of U-74500A-dependent inhibition probably involved interactions with iron, as iron oxidation was inhibited in the presence of this compound. No effects on iron oxidation were observed in the presence of U-74006F. Addition of Ferrozine to liposomal incubation mixtures indicated that at least two iron pools were present in samples containing U-74500A, one immediately bound by Ferrozine, and another that was bound more slowly. Furthermore, ADP:Fe(III)/ascorbate-dependent lipid peroxidation was blocked completely by U-74500A, presumably by formation of a redox inert complex upon reduction of the iron. U-74500A partially protected ADP:Fe(II) from oxidation by H2O2 and lipid hydroperoxides, indicating that the U-74500A:iron complex was stable in the presence of biologically relevant oxidants. U-74006F did not markedly affect iron oxidation or reduction when incorporated into phospholipid liposomes. In microsomal lipid peroxidation systems containing ADP:Fe(III) and NADPH, both U-74500A and U-74006F inhibited lipid peroxidation. U-74006F-dependent inhibition of microsomal lipid peroxidation was dependent on both NADPH and Fe(III). Further, it was enhanced when U-74006F was allowed to preincubate in this system prior to iron addition. Preincubation of U-74006F with microsomes, NADPH, and ADP:Fe(III) produced several metabolites detectable by HPLC. These results suggest that U-74500A inhibits lipid peroxidation by directly affecting iron redox chemistry, whereas U-74006F-mediated inhibition is enhanced by preincubation with a metabolically competent microsomal system.
在之前的一份报告中(瑞安和佩特里,《生物化学与生物物理学报》300: 699 - 704,1993年),研究了两种21 - 氨基类固醇(U - 74500A和U - 74006F)对缓冲液/有机溶剂体系中铁氧化和还原的影响。在那些研究中,发现U - 74500A是一种有效的铁还原剂和潜在的铁螯合剂,而U - 74006F对铁的氧化还原化学几乎没有影响。作为这些研究的扩展,我们现在报告U - 74006F和U - 74500A对依赖铁氧化/还原的体系中脂质过氧化的影响。在脂质体中,U - 74500A以浓度依赖的方式抑制ADP:Fe(II)依赖性脂质过氧化,而U - 74006F在该体系中效果甚微。U - 74500A依赖性抑制的机制可能涉及与铁的相互作用,因为在该化合物存在下铁氧化受到抑制。在U - 74006F存在下未观察到对铁氧化的影响。向脂质体孵育混合物中添加菲咯嗪表明,在含有U - 74500A的样品中至少存在两个铁池,一个立即被菲咯嗪结合,另一个结合较慢。此外,U - 74500A完全阻断了ADP:Fe(III)/抗坏血酸依赖性脂质过氧化,推测是通过铁还原后形成氧化还原惰性复合物。U - 74500A部分保护ADP:Fe(II)不被H2O2和脂质氢过氧化物氧化,表明U - 74500A:铁复合物在生物学相关氧化剂存在下是稳定的。当U - 74006F掺入磷脂脂质体时,对铁的氧化或还原没有明显影响。在含有ADP:Fe(III)和NADPH的微粒体脂质过氧化体系中,U - 74500A和U - 74006F均抑制脂质过氧化。U - 74006F对微粒体脂质过氧化的抑制依赖于NADPH和Fe(III)。此外,当在添加铁之前让U - 74006F在该体系中预孵育时,抑制作用增强。U - 74006F与微粒体、NADPH和ADP:Fe(III)预孵育产生了几种可通过高效液相色谱检测到的代谢产物。这些结果表明,U - 74500A通过直接影响铁的氧化还原化学来抑制脂质过氧化,而U - 74006F介导的抑制作用通过与代谢活性微粒体系统预孵育而增强。